Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Wave Life Sciences USA, Inc.

Wave Life Sciences Announces Topline Results from Phase 1b/2a FOCUS-C9 Study of WVE-004 for C9orf72-associated Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Tickers WVE
Wave Life Sciences to Highlight Leading RNA Editing Capability and Multimodal Discovery and Development Platform at ASGCT 26th Annual Meeting
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Tickers WVE
Wave Life Sciences Reports First Quarter 2023 Financial Results and Provides Business Update
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Tickers WVE
Wave Life Sciences First Quarter 2023 Financial Results Scheduled for May 3, 2023
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Tickers WVE
Wave Life Sciences Announces Nucleic Acids Research Publication Highlighting Potential Best-in-Class siRNAs Designed with Wave Platform Chemistry
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Tickers WVE
Wave Life Sciences to Present at the Guggenheim Genomic Medicines and Rare Disease Days
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Tickers WVE
Wave Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Tickers WVE
Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Tickers WVE
Wave Life Sciences to Present at the 2023 Virtual SVB Securities Global Biopharma Conference
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Tickers WVE
Wave Life Sciences Provides Positive Update on Proof-of-Concept Study for WVE-N531 in Duchenne Muscular Dystrophy
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Tickers WVE
Wave Life Sciences and GSK Announce Collaboration to Drive Discovery and Development of Oligonucleotide Therapeutics Focusing on Novel Genetic Targets
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Tickers GSK WVE
Wave Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Tickers WVE
Wave Life Sciences to Present at the Stifel 2022 Healthcare Conference
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Tickers WVE
Wave Life Sciences to Webcast Conference Call of Third Quarter 2022 Financial Results on November 10, 2022
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Tickers WVE
Wave Life Sciences to Highlight Advancements from PRISM Platform at Upcoming Scientific Congresses
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Tickers WVE
Wave Life Sciences Highlights Therapeutic Potential for WVE-006 for Alpha-1 Antitrypsin Deficiency and Progress Bringing RNA Editing to the Clinic During Analyst and Investor Event
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Tickers WVE
Wave Life Sciences to Webcast Conference Call of Second Quarter 2022 Financial Results on August 11, 2022
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
Tickers WVE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.